About DexCom

DexCom (NASDAQ:DXCM) is a company specializing in the development, manufacturing, and distribution of continuous glucose monitoring (CGM) systems for people with diabetes. These pioneering CGM systems are designed to help patients and healthcare professionals monitor and manage glucose levels in real-time, lending support towards more informed treatment decisions and better glycemic control. Aimed at enhancing the quality of life for individuals living with diabetes, DexCom is committed to advancing technology that can lead to more seamless and effective diabetes management. The company's projects include not only improving the accuracy and usability of its CGM devices but also integrating its technology with a variety of digital health platforms and devices to offer comprehensive diabetes management solutions. DexCom's objectives focus on innovation, accessibility, and continuing to meet the evolving needs of the diabetes community worldwide.

Snapshot

Public USOwnership

1999Year founded

6162Employees

San Diego, United StatesHead office

Loading Map...

Global footprint

Operations

All Locations

San Diego, US

Products and/or services of DexCom

Continuous Glucose Monitoring (CGM) Systems for diabetes management, offering real-time glucose readings and trends.
The Dexcom G6 CGM, providing no-calibration glucose monitoring with a slim, water-resistant sensor.
Dexcom CLARITY diabetes management software, offering insights and reporting for both patients and healthcare providers.
Dexcom G7, the next-generation CGM system, designed for easier and more discreet diabetes management.
Dexcom ONE, a simpler and more affordable CGM solution aimed at broader access to glucose monitoring.
Integration solutions with insulin pumps and other digital health apps for cohesive diabetes management.

DexCom executive team

Mr. Jacob Steven LeachPresident, CEO & Director
Mr. Kevin Ronald SayerExecutive Chairman of the Board (Leave of Absence)
Mr. Jereme M. Sylvain CPAExecutive VP, CFO & Chief Accounting Officer
Mr. Michael Jon BrownExecutive VP & Chief Legal Officer
Ms. Sadie M. SternExecutive VP & Chief Human Resources Officer
Mr. Girish NaganathanExecutive VP & CTO
Mr. Sean ChristensenVice President of Finance and Investor Relations
Mr. Matthew DolanExecutive Vice President of Strategy & Corporate Development
Mr. Donald M. AbbeyExecutive Vice President of Global Business Services, Regulatory, Medical & Clinical Affairs
Mr. Jon ColemanExecutive VP & Chief Commercial Officer